The resolution asks the FDA to review abortion pill safety again. It also asks the agency to share a full public report on real-world problems and outcomes. It does not change access rules by itself.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes. is a House bill in committee. The latest recorded action: Referred to the House Committee on Energy and Commerce.
Latest action on H.Res. 803: Referred to the House Committee on Energy and Commerce.
Who this affects: This bill mainly affects people who use or may use abortion pills, health care providers who prescribe them, and pharmacies that dispense them. It could also matter to the FDA, drug makers, and groups involved in abortion policy. The real impact depends on whether the FDA follows the request and what any review finds.
Why this matters: This matters because abortion pills are widely used, and the resolution could push the FDA to revisit how safe they are in real life. A new review could affect labels, monitoring, or rules for getting the drugs in the future. It also sits inside a larger fight over abortion access, FDA authority, and state abortion laws. The resolution only asks the FDA to act, so the practical effect is uncertain.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Keep acting on Modern Action
Compare the broader issue and related bills without leaving Modern Action.
Officially: Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
The resolution asks the FDA to review abortion pill safety again. It also asks the agency to share a full public report on real-world problems and outcomes. It does not change access rules by itself.
Use this page to support, oppose, or ask Congress to amend HRES803. Modern Action explains Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes. in plain English, helps identify the right senators or representative, and drafts a bill-specific message you can edit and send.
Where it stands
Sitting in House Committee
No vote scheduled. Constituent contact is what moves bills out of committee.
↓ Why your message matters here
This bill is sitting in committee with no scheduled vote — which means a small number of constituent messages can decide whether it moves forward or quietly dies.
Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.
Where this bill is in the process
Introduced
Introduced in House
House Committee
Under House committee consideration
Latest: Referred to the House Committee on Energy and Commerce. (10/10/2025)
House Floor Vote
Voted on by House
Agreed to in House
Adopted by House
For more detail
Choose one clear position: support, oppose, or amend. Then pick any reasons or personal context you want included. Modern Action uses that input and the bill context to draft a message you can edit and send.
Congressional offices prioritize messages from their own constituents. Modern Action uses your address to route the drafted message to your House representative when that is the most relevant target for this bill.
The draft includes the bill number, your position, the reasons you selected, any personal context you added, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes. You stay in control because you can edit the message before sending.
This page gives you an opportunity to support, oppose, or ask for changes to Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes., then contact the elected officials who can act. Modern Action drafts the message from your position and the reasons you select.
Modern Action keeps the action tied to the bill itself: what it would do, where it is in the process (committee), which office can still act, and what ask belongs in the message.
You are not starting from a blank form. Modern Action drafts the message around HRES803, your stance, and the reasons you choose, then lets you edit and send when ready.
